A pilot study investigating affective forecasting biases with a novel virtual reality-based paradigm.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 06 2023
Historique:
received: 27 11 2022
accepted: 01 06 2023
medline: 12 6 2023
pubmed: 9 6 2023
entrez: 8 6 2023
Statut: epublish

Résumé

A body of research indicates that people are prone to overestimate the affective impact of future events. Here, we developed a novel experimental paradigm to study these affective forecasting biases under laboratory conditions using subjective (arousal and valence) and autonomic measures (skin conductance responses, SCRs, and heart rate). Thirty participants predicted their emotional responses to 15 unpleasant, 15 neutral, and 15 pleasant scenarios (affective forecasting phase) to which they were then exposed in virtual reality (emotional experience phase). Results showed that participants anticipated more extreme arousal and valence scores than they actually experienced for unpleasant and pleasant scenarios. The emotional experience phase was characterized by classic autonomic patterns, i.e., higher SCRs for emotionally arousing scenarios and greater peak cardiac acceleration for pleasant scenarios. During the affective forecasting phase, we found only a moderate association between arousal scores and SCRs and no valence-dependent modulation of cardiac activity. This paradigm opens up new perspectives for investigating affective forecasting abilities under lab-controlled conditions, notably in psychiatric disorders with anxious anticipations.

Identifiants

pubmed: 37291205
doi: 10.1038/s41598-023-36346-3
pii: 10.1038/s41598-023-36346-3
pmc: PMC10250404
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9321

Informations de copyright

© 2023. The Author(s).

Références

Brain Cogn. 2021 Jun;150:105708
pubmed: 33714004
Neuropsychologia. 2020 Sep;146:107525
pubmed: 32535130
Front Hum Neurosci. 2010 Apr 19;4:33
pubmed: 20428514
Behav Res Ther. 2006 Jun;44(6):861-82
pubmed: 16126162
Nat Rev Neurosci. 2007 Sep;8(9):657-61
pubmed: 17700624
Emotion. 2022 Sep 08;:
pubmed: 36074619
J Behav Ther Exp Psychiatry. 1994 Mar;25(1):49-59
pubmed: 7962581
Psychol Sci. 2008 Sep;19(9):865-73
pubmed: 18947351
Science. 2007 Sep 7;317(5843):1351-4
pubmed: 17823345
Nat Rev Neurosci. 2013 Feb;14(2):143-52
pubmed: 23329161
Int J Psychophysiol. 2009 Apr;72(1):13-23
pubmed: 18938199
Int J Psychophysiol. 2009 Jan;71(1):50-6
pubmed: 18723054
J Pers Soc Psychol. 2000 May;78(5):821-36
pubmed: 10821192
Soc Cogn Affect Neurosci. 2017 Jan 1;12(1):1-23
pubmed: 27798257
J Soc Psychol. 2009 Jun;149(3):343-8
pubmed: 19537599
Philos Trans R Soc Lond B Biol Sci. 2009 May 12;364(1521):1335-41
pubmed: 19528015
Pers Soc Psychol Bull. 2003 Nov;29(11):1421-32
pubmed: 15189579
Trends Cogn Sci. 2015 Apr;19(4):196-200
pubmed: 25726365
Psychophysiology. 1993 May;30(3):261-73
pubmed: 8497555
Biol Psychol. 2010 Jul;84(3):437-50
pubmed: 19879918
J Exp Psychol Gen. 2011 May;140(2):258-71
pubmed: 21401291
Emotion. 2013 Dec;13(6):1023-9
pubmed: 23914762
Behav Res Ther. 2018 Jul;106:37-46
pubmed: 29758391
Behav Ther. 2020 May;51(3):365-374
pubmed: 32402253
Psychol Rev. 2003 Jul;110(3):403-21
pubmed: 12885109
Trends Cogn Sci. 2007 Feb;11(2):49-57
pubmed: 17188554
Pers Soc Psychol Bull. 2012 Jul;38(7):895-906
pubmed: 22649114
Emotion. 2001 Sep;1(3):276-98
pubmed: 12934687

Auteurs

Louise Loisel-Fleuriot (L)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000, Lille, France.

Thomas Fovet (T)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000, Lille, France.
Department of Psychiatry, CHU Lille, 59000, Lille, France.

Arnaud Bugnet (A)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000, Lille, France.

Coralie Creupelandt (C)

Centre National de Ressources et de Résilience Lille-Paris (CN2R), 59000, Lille, France.

Marielle Wathelet (M)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000, Lille, France.
Department of Psychiatry, CHU Lille, 59000, Lille, France.
Centre National de Ressources et de Résilience Lille-Paris (CN2R), 59000, Lille, France.
Fédération de Recherche en Psychiatrie et Santé Mentale des Hauts-de-France, 59000, Lille, France.

Sébastien Szaffarczyk (S)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000, Lille, France.

Stéphane Duhem (S)

Department of Psychiatry, CHU Lille, 59000, Lille, France.
Centre National de Ressources et de Résilience Lille-Paris (CN2R), 59000, Lille, France.
Fédération de Recherche en Psychiatrie et Santé Mentale des Hauts-de-France, 59000, Lille, France.
Univ. Lille, Inserm, CHU Lille, CIC1403 - Clinical Investigation Center, 59000, Lille, France.

Guillaume Vaiva (G)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000, Lille, France.
Department of Psychiatry, CHU Lille, 59000, Lille, France.
Centre National de Ressources et de Résilience Lille-Paris (CN2R), 59000, Lille, France.

Mathilde Horn (M)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000, Lille, France.
Department of Psychiatry, CHU Lille, 59000, Lille, France.

Fabien D'Hondt (F)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000, Lille, France. fabien.d-hondt@univ-lille.fr.
Department of Psychiatry, CHU Lille, 59000, Lille, France. fabien.d-hondt@univ-lille.fr.
Centre National de Ressources et de Résilience Lille-Paris (CN2R), 59000, Lille, France. fabien.d-hondt@univ-lille.fr.
CURE, Service de Psychiatrie de L'enfant et de L'adolescent, Hôpital Fontan 1, CHU de Lille, CS 70001, 59037, Lille cedex, France. fabien.d-hondt@univ-lille.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH